VistaGen announces annual shareholder meeting - VTGN News | RalliesVistaGen announces annual shareholder meeting
V
VTGN• Annual meeting details and proposals
- VistaGen Therapeutics will hold its 2026 annual stockholders meeting virtually on Sept. 10, 2026.
- Shareholders will vote to elect four director nominees: Jon S. Saxe, Ann M. Cunningham, Shawn K. Singh, and Douglas J. Williamson.
- An advisory vote is scheduled on executive compensation for named executive officers.
- A ratification vote is set on KPMG as independent registered public accounting firm for the fiscal year ending March 31, 2027.
BRIA
•
